These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6310486)

  • 41. [Surgical treatment and radiation therapy for glioblastoma multiforme, with special reference to intraoperative radiotherapy].
    Matsutani M; Matsuda T; Nagashima T; Kohno T; Hoshino T; Terao H
    Gan No Rinsho; 1984 Apr; 30(4):325-33. PubMed ID: 6328061
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Further studies in serum enzyme activity during split-course radiotherapy of malignant tumours.
    Holsti LR
    Ann Med Intern Fenn; 1967; 56(4):189-93. PubMed ID: 4968062
    [No Abstract]   [Full Text] [Related]  

  • 43. [Changes in the irradiation technic in the treatment of tumors of the colon and rectum in connection with the gradual use of higher energy irradiation].
    Chvojka Z; Blaha V; Janousek Z; Urbanová E; Vrastilová P; Vycichlová J
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1978; 21(4):475-81. PubMed ID: 119313
    [No Abstract]   [Full Text] [Related]  

  • 44. [Carbohydrate metabolism in neoplastic processes].
    Miloslavskiĭ IM; Dyshlevaia LN; Buntser IaM
    Vopr Onkol; 1972; 18(3):74-8. PubMed ID: 5017842
    [No Abstract]   [Full Text] [Related]  

  • 45. [Preoperative radiotherapy of locally advanced colo-rectal-anal cancer].
    Fosså SD
    Tidsskr Nor Laegeforen; 1983 Aug; 103(22):1523-4. PubMed ID: 6636063
    [No Abstract]   [Full Text] [Related]  

  • 46. Comparison of binding of [3H]misonidazole and [14C]misonidazole in multicell spheroids.
    Rasey JS; Grunbaum Z; Krohn K; Nelson N; Chin L
    Radiat Res; 1985 Mar; 101(3):473-9. PubMed ID: 3983363
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Circadian changes in the elimination of misonidazole in mouse.
    Labat C; Malmary MF; Casanovas AM; Patau JP; Oustrin J
    Res Commun Chem Pathol Pharmacol; 1983 Nov; 42(2):331-4. PubMed ID: 6658193
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Distribution of misonidazole in human tumours and normal tissues.
    Ash DV; Smith MR; Bugden RD
    Br J Cancer; 1979 May; 39(5):503-9. PubMed ID: 486305
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phenytoin-induced changes in the pharmacokinetics of misonidazole in radiotherapy patients.
    Moore JL; Paterson IC; Newman H; Venables S
    Br J Cancer; 1981 Oct; 44(4):592-6. PubMed ID: 7295516
    [No Abstract]   [Full Text] [Related]  

  • 50. No significant effect of metoclopramide on misonidazole elimination in man.
    Williams KM; Begg EJ; Wade DN; O'Shea K
    Br J Clin Pharmacol; 1983 Mar; 15(3):390-2. PubMed ID: 6849772
    [No Abstract]   [Full Text] [Related]  

  • 51. Misonidazole-a drug for trial in radiotherapy and oncology.
    Dische S; Saunders MI; Flockhart IR; Lee ME; Anderson P
    Int J Radiat Oncol Biol Phys; 1979 Jun; 5(6):851-60. PubMed ID: 227822
    [No Abstract]   [Full Text] [Related]  

  • 52. The role of dexamethasone in the modification of misonidazole pharmacokinetics.
    Jones DH; Bleehen NM; Workman P; Walton MI
    Br J Cancer; 1983 Oct; 48(4):553-7. PubMed ID: 6626454
    [TBL] [Abstract][Full Text] [Related]  

  • 53. No significant effect of cimetidine on the pharmacokinetics of misonidazole in man.
    Begg EJ; Williams KM; Wade DN; O'Shea KF
    Br J Clin Pharmacol; 1983 May; 15(5):575-6. PubMed ID: 6860535
    [No Abstract]   [Full Text] [Related]  

  • 54. Biliary and faecal excretion of misonidazole in man.
    Ash DV; Smith MR
    Br J Radiol; 1979 Oct; 52(622):846-8. PubMed ID: 509037
    [No Abstract]   [Full Text] [Related]  

  • 55. A drug for improved radiosensitization in radiotherapy.
    Dische S; Fowler JF; Saunders MI; Stratford MR; Anderson P; Minchinton AI; Lee ME
    Br J Cancer; 1980 Jul; 42(1):153-5. PubMed ID: 7426325
    [No Abstract]   [Full Text] [Related]  

  • 56. Reductive fragmentation of 2-nitroimidazoles in the presence of nitroreductases--glyoxal formation from misonidazole.
    Raleigh JA; Liu SF
    Biochem Pharmacol; 1983 Apr; 32(8):1444-6. PubMed ID: 6687998
    [No Abstract]   [Full Text] [Related]  

  • 57. Binding of misonidazole to V79 spheroids and fragments of Dunning rat prostatic and human colon carcinomas in vitro: diffusion of oxygen and reactive metabolites.
    Franko AJ; Koch CJ
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1333-6. PubMed ID: 6469756
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Causes of apparent low levels of misonidazole in human tumours.
    Ash DV; Smith MR
    Clin Radiol; 1980 Mar; 31(2):233-7. PubMed ID: 7363558
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Initial United States clinical and pharmacologic evaluation of misonidazole (Ro-07-0582), an hypoxic cell radiosensitizer.
    Wasserman TH; Phillips TL; Johnson RJ; Gomer CJ; Lawrence GA; Sadee W; Marques RA; Levin VA; VanRaalte G
    Int J Radiat Oncol Biol Phys; 1979 Jun; 5(6):775-86. PubMed ID: 227821
    [No Abstract]   [Full Text] [Related]  

  • 60. Intracellular localization of radioactively labeled misonidazole in EMT-6-tumor cells in vitro.
    Miller GG; Ngan-Lee J; Chapman JD
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):741-4. PubMed ID: 7107408
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.